Luke Walker, M.D — Zentalis Pharmaceuticals Director Compensation (2025)

What they were paid

Zentalis Pharmaceuticals Director Compensation Table · the one fiscal year held

In US dollars, as Zentalis Pharmaceuticals reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal year	Cash fees	Stock awards	Option awards	Other	Total
FY2025	$58,861	$86,405	$0	$0	$145,266

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Zentalis Pharmaceuticals, Inc. DEF 14A filed April 30, 2026, accession 0001725160-26-000027, and prior-year filings. Open the filing on EDGAR.

How this board is paid

company policy · FY2025

Zentalis Pharmaceuticals pays directors a $45,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Audit · Compensation · Nominating/Governance

The rest of the Zentalis Pharmaceuticals board

FY2025 · as the company reported each

Director	Role	FY2025 total
David Johnson	Independent Director	$139,251
Enoch Kariuki, Pharm.D	Independent Director	$151,405
Jan Skvarka, Ph.D	Independent Director	$151,405
Julie Eastland	Director	$0
Scott Myers	Independent Director	$184,136

The full Zentalis Pharmaceuticals compensation record

free company brief

This page is one director within Zentalis Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat